A randomized, open-label, parallel-group, multi-center trial to compare efficacy and safety of TachoSil® versis Surgicel® Original for the secondary hemostatic treatment of needle hole bleeding in vascular surgery

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/121/1/12